Contracts › 75N94023F00003
75N94023F00003: Finalization, Procurement of Regulatory Approval, and Complete Start-Up Activities for the Ovaprene Vaginal Device Clinical Trial
Awarded to Health Decisions, Inc. by National Institutes of Health (NIH).
$2.2Mobligated
$2.2Mpotential value
31 July 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94023F00003 |
|---|---|
| Vehicle | 75N94019D00004 |
| Awardee | Health Decisions, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Period of performance | 01 September 2023 to 31 July 2027 |
| Potential end | 31 July 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record